Ovid Therapeutics, Inc. (OVID)
2.80
+0.04
(+1.45%)
USD |
NASDAQ |
Apr 16, 16:00
2.805
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics EPS Diluted (Quarterly) : 0.1183 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -1.673 |
| CytomX Therapeutics, Inc. | -0.1734 |
| Artelo Biosciences, Inc. | -6.191 |
| Eton Pharmaceuticals, Inc. | 0.0475 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 9.664M |
| Revenue (Quarterly) | 0.718M |
| Total Expenses (Quarterly) | -8.946M |
| Enterprise Value | 366.67M |
| Gross Profit Margin (Quarterly) | 93.87% |
| Earnings Yield | -9.38% |
| Normalized Earnings Yield | -2.929 |